BAFNAPH.NS Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 apr 2024 @ 10:54):

Bafna Pharmaceuticals Limited manufactures and sells finished pharmaceutical formulations in India. The company provides delayed and sustained release, chewable, and orally disintegrating tablets...

Stats
Dagens volum	8 330.00
Gjennomsnittsvolum	6 631.00
Markedsverdi	2.14B
EPS	INR0 ( 2024-02-11 )
Neste inntjeningsdato	( INR0 ) 2024-05-21
Last Dividend	INR0.600 ( 2013-09-19 )
Next Dividend	INR0 ( N/A )
P/E	18.93
ATR14	INR0.656 (0.73%)

Bafna Pharmaceuticals Korrelasjon

10 Mest positive korrelasjoner
BUTTERFLY.NS	0.955
CLNINDIA.NS	0.942
DIAMONDYD.NS	0.936
BAYERCROP.NS	0.935
FSC.NS	0.934
EASTSILK.NS	0.933
INDIAGLYCO.NS	0.93
TATVA.NS	0.929
ROLTA.NS	0.928
AJRINFRA.NS	0.927

10 Mest negative korrelasjoner
HARIOMPIPE.NS	-0.932
CIGNITITEC.NS	-0.921
CONTROLPR.NS	-0.92
SONATSOFTW.NS	-0.918
BECTORFOOD.NS	-0.91
KAYNES.NS	-0.91
CLSEL.NS	-0.91
GEEKAYWIRE.NS	-0.909
TARMAT.NS	-0.904
JMCPROJECT.NS	-0.901

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Bafna Pharmaceuticals Økonomi

Annual	2022
Omsetning:	INR1.15B
Bruttogevinst:	INR387.56M (33.60 %)
EPS:	INR4.79

FY	2022
Omsetning:	INR1.15B
Bruttogevinst:	INR387.56M (33.60 %)
EPS:	INR4.79

FY	2022
Omsetning:	INR851.40M
Bruttogevinst:	INR338.55M (39.76 %)
EPS:	INR2.17

FY	2021
Omsetning:	INR712.18M
Bruttogevinst:	INR257.62M (36.17 %)
EPS:	INR2.46

Financial Reports:

No articles found.

Bafna Pharmaceuticals Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Bafna Pharmaceuticals Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 3.98 - low (32.33%) | Divividend Growth Potential Score: 2.74 - No dividend growth expected in the near future

Information

First Dividend	INR0.600	2013-09-19
Last Dividend	INR0.600	2013-09-19
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	1	--
Total Paid Out	INR0.600	--
Avg. Dividend % Per Year	0.00%	--
Score	1.02	--
Div. Sustainability Score	3.98
Div.Growth Potential Score	2.74
Div. Directional Score	3.36	--

Next Divdend (Est)
(2024-04-29)

INR0 Estimate 0.00 %

Dividend Stability

0.00 Very Bad

Dividend Score

1.02

Pay Frequency

Insufficient data to determine frequency

Yearly Payout

Year	Amount	Yield
2013	INR0	0.00%
2014	INR0	0.00%
2015	INR0	0.00%
2016	INR0	0.00%
2017	INR0	0.00%
2018	INR0	0.00%
2019	INR0	0.00%
2020	INR0	0.00%
2021	INR0	0.00%
2022	INR0	0.00%
2023	INR0	0.00%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
SANDHAR.NS	Dividend Junior	2023-09-14	Annually	7	0.66%
LXCHEM.NS	Dividend Junior	2023-07-20	Annually	4	0.11%
GLENMARK.NS	Dividend Junior	2023-09-18	Annually	23	0.37%
ASIANPAINT.NS	Dividend Junior	2023-06-09	Semi-Annually	23	0.43%
TINPLATE.NS	Dividend Junior	2023-08-11	Annually	19	0.72%
PDMJEPAPER.NS	Dividend Junior	2023-08-03	Annually	9	0.65%
J&KBANK.NS	Dividend Junior	2023-08-17	Sporadic	22	0.47%
DATAMATICS.NS	Dividend Junior	2023-09-22	Annually	21	0.49%
SHYAMMETL.NS	Dividend Junior	2023-06-05	Semi-Annually	4	0.70%
MAXHEALTH.NS	Dividend Junior	2023-09-08	Insufficient data to determine frequency	2	0.07%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0735	1.500	8.53	10.00	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.145	1.500	9.50	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	5.17	1.000	9.20	9.20	[3 - 30]
operatingCashFlowPerShareTTM	4.44	2.00	8.52	10.00	[0 - 30]
freeCashFlowPerShareTTM	4.44	2.00	7.78	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.305	1.000	8.25	8.25	[0.2 - 0.8]
operatingProfitMarginTTM	0.0782	1.000	-0.436	-0.436	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				3.98

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	18.96	1.000	8.19	0	[1 - 100]
returnOnEquityTTM	0.145	2.50	9.68	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	4.44	2.00	8.52	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	4.44	2.00	8.52	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-1.866	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0685	1.000	-0.788	0	[0.1 - 0.5]
Total Score				2.74

Bafna Pharmaceuticals

Bafna Pharmaceuticals Limited manufactures and sells finished pharmaceutical formulations in India. The company provides delayed and sustained release, chewable, and orally disintegrating tablets. It also exports its products. Bafna Pharmaceuticals Limited was founded in 1981 and is based in Chennai, India.